Meconium aspiration syndrome is a clinical condition characterized by respiratory failure
occurring in neonates born through meconium-stained amniotic fluid. Worldwide, the …

Green-stained amniotic fluid, often referred to as meconium-stained amniotic fluid, is present
in 5% to 20% of patients in labor and is considered an obstetric hazard. The condition has …

Objective To assess whether endotracheal suctioning of nonvigorous infants born through
meconium stained amniotic fluid (MSAF) reduces the risk and complications of meconium …

Background Current evidence on vertical transmission of severe acute respiratory syndrome
Coronavirus 2 (SARS-CoV-2) and neonatal outcome among exposed newborns is emerging …

The epidemiology of meconium aspiration syndrome (MAS) in term neonates is described in
a population‐based retrospective study of data recorded for all births from 2000 to 2007 in a …

Infants born through meconium-stained amniotic fluid (MSAF) are 100 times more likely than
infants born through clear amniotic fluid to develop respiratory distress in the neonatal …

Objective: To determine the maternal factors and neonatal outcome of pregnancy
complicated by meconium stained amniotic fluid. Methods: This one year retrospective study …

One in every 7 pregnancies ends with meconium-stained amniotic fluid and approximately
5% of these infants develop the meconium aspiration syndrome (MAS). MAS is a severe …

Background Meconium-stained amniotic fluid (MSAF) is a condition in which meconium is
present in the uterus during ante-natal and complicates 10–15% of all live births. Scanty …

Whether meconium-stained amniotic fluid (MSAF) serves as an indicator of fetal distress is
under debate; however, the presence of MSAF concerns both obstetricians and …